National Black HIV/AIDS Awareness Day
President, Founder and CEO of Black AIDS Institute, Phill Wilson, released a letter in light of the 12th annual National Black HIV/AIDS Awareness Day, stating that the Institute will be releasing their 8th annual State of AIDS in Black America Report. He comments that It will highlight a reality that would have been unthinkable not long ago. Wilson continues: We are at a deciding moment in the trajectory of the AIDS epidemic; we now possesses the tools we need to the the AIDS epidemic... (Source: Health News from Medical News Today)
FDA Approves Nevirapine (Viramune XR) Extended Release Tablet
ldquo;On March 25, 2011, FDA approved VIRAMUNE XR (nevirapine), a 400 mg extended release tablet formulation. hellip;
ldquo;The approval is based on one principal clinical trial hellip; that demonstrated prolonged suppression of HIV-1 RNA through 48-weeks, and a supportive trial hellip; .
ldquo;Additional important information regarding the use of VIRAMUNE XR for the treatment of HIV-1 infection:
ldquo;Based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled studies, nevirapine should not be initiated in adult females with CD4+ cell counts greater than 250 cells/mm3 or in adult males with CD4+ cell counts greater than 400 cells/mm3 unless the benefit outweighs the risk
ldquo;The 14-day lead-in period with immediate-release VIRAMUNE ...
